Home » Authors » Cormac Sheridan

Cormac Sheridan

Articles

ARTICLES

Berna Biotech's Spinout Kenta Raises CHF10M For Antibodies

May 10, 2006

By Cormac Sheridan

Borean Out-Licensing Apo A-I Atherosclerosis Drug To Roche

May 10, 2006

By Cormac Sheridan

Evotec Grosses EUR18.5M In Placement For CNS Drugs

May 3, 2006

By Cormac Sheridan

Pharmexa Moves GV1001 Into Pivotal Cancer Study

May 3, 2006

By Cormac Sheridan

Pharmexa Moves GV1001 Into Pivotal Cancer Study

May 3, 2006

By Cormac Sheridan

Evotec Grosses EUR18.5M In Placement For CNS Drugs

May 3, 2006

By Cormac Sheridan

Serono Hits Acquisition Trail In Search Of Adding Growth

April 26, 2006

By Cormac Sheridan

Serono Hits Acquisition Trail In Search Of Adding Growth

April 26, 2006

By Cormac Sheridan

Launch Of Europe's First Biogeneric Drug Imminent

April 19, 2006

By Cormac Sheridan

Rising TopoTarget Earns Priority Review From FDA

April 19, 2006

By Cormac Sheridan

View All Articles by Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...